Beautiful Blog

Rubius Therapeutics, Inc. The company reported ($0.50) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.53) by $0.03. NASDAQ:RUBY Setting a nice bullish consolidation. Get short term trading ideas from the MarketBeat Idea Engine. Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Find out now with a free analysis on Rubius Therapeutics. Rubius (RUBY) Stock Performance and Technical Trend Chart View : RUBY Recent Price: 22.50 : MarketCap: 2947.69 Millions : Day Percent Change: 1.08% : Day Change: 0.24 : Week Change: -5.78% : Year-to-date Change: 196.44% : Weekly RUBY Technical Chart Daily RUBY Technical Chart Add RUBY To Watch List View List: 12Stocks.com Short Term Trend Analysis for RUBY : 46 / 100: The current … It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. Pablo Cagnoni has an approval rating of 91% among Rubius Therapeutics' employees. In 2023, RUBY's EPS is forecast … These intraday share price levels are calculated using pivot point calculations and valid only for tomorrow's session on a 5-15 minute chart. This puts Pablo Cagnoni in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. RUBY 24.05 … Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Rubius Therapeutics in the last twelve months. Vote “Underperform” if you believe RUBY will underperform the S&P 500 over the long term. All times are ET. Rubius Therapeutics Inc. stock price ended on $23.88 on Friday after losing 1.04% (Updated on April 09, 2021) The Rubius Therapeutics Inc. stock price fell by -1.04% on the last day (Friday, 9th Apr 2021) from $24.13 to $23.88. DOW 0.00%. Since then, RUBY stock has increased by 271.0% and is now trading at $24.30. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. View our full suite of financial calendars and market data tables, all for free. About the Hotel Rugby Ltd. stock forecast. S&P 500 0.00%. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Rubius Therapeutics' mailing address is 399 BINNEY STREET SUITE 300, CAMBRIDGE MA, 02139. - DreamHackers All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. Over the past year the S&P 500 has gained 14.94% while RUBY has fallen -45.51%. Sign Up. Factset: FactSet Research Systems Inc.2019. Rubius Therapeutics, Inc. (NASDAQ:RUBY) posted its quarterly earnings results on Tuesday, February, 23rd. The company issued 9,500,000 shares at a price of $20.00-$22.00 per share. S&P 500 4,128.80. Delayed Data. NASDAQ:RUBY - Rubius Therapeutics Stock Price Target and Predictions. All Rights Reserved. (Add your “outperform” vote. Rubius Therapeutics has received 54.84% “underperform” votes from our community. Identify stocks that meet your criteria using seven unique stock screeners. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Wall Street analysts have given Rubius Therapeutics a "Hold" rating, but there may be better short-term opportunities in the market. There are currently 3 hold ratings and 1 buy rating for the stock. As of 2021 April 05, Monday current price of 526683 stock is 1.200$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Hotel Rugby stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame. A high percentage of insider ownership can be a sign of company health. Ruby Mills RUBYMILLS forecast & targets Ruby Mills RUBYMILLS share price forecast & targets for Intra Day are 169.45, 167.15, 162.95 on the downside, and 178.25, 175.95, 180.55 on the upside. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Rubius Therapeutics does not currently pay a dividend. Rubius Therapeutics Inc (NASDAQ:RUBY) Rubius Therapeutics Inc. (NASDAQ:RUBY) 23.95. MarketBeat's community ratings are surveys of what our community members think about Rubius Therapeutics and other stocks. Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. Rubius Therapeutics, Inc. (NASDAQ:RUBY) Stock Forecast: Bullish Sentiment Portends 23.88% Upside in 2021. RUBY Stock Forecast - Is RUBY a buy or sell? 4.20. Real-time trade and investing ideas on Rubius Therapeutics, Inc. RUBY from the largest community of traders and investors. Rubis Stock Price Forecast, "RUI" Predictons for2021. RUBY lost -$2.14 per share the over the last 12 months. Log In. Click Here to get the full report on Rubius Therapeutics Inc (RUBY) Stock. Rubius Therapeutics trades on the NASDAQ under the ticker symbol "RUBY.". The P/E ratio of Rubius Therapeutics is -11.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Rubius Therapeutics has generated ($2.08) earnings per share over the last year. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Nasdaq 100. Rubius Therapeutics' stock was trading at $6.55 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. According to analysts' consensus price target of $23.33, Rubius Therapeutics has a forecasted downside of 4.0% from its current price of $24.30. What this means: Rubius Therapeutics Inc (RUBY) gets an Overall Rank of 62, which is an above average rank under InvestorsObserver's stock ranking system. On average, they anticipate the Rubicon Project's stock price to reach $9.50 in the next twelve months. View Rubius Therapeutics' Short Interest. High institutional ownership can be a signal of strong market trust in this company. 326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257 Date Range. Rubius Therapeutics does not have a long track record of dividend growth. The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Rubius Therapeutics employs 204 workers across the globe. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts. Rubius Therapeutics, Inc. (RUBY) stock forecast and price target. Rubius Therapeutics (RUBY) stock was flying high on Monday after announcing early results from a clinical trial of its new cancer treatment. On average, they expect Rubius Therapeutics' stock price to reach $23.33 in the next year. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RUBY, but not buy additional shares or sell existing shares. See what's happening in the market right now with MarketBeat's real-time news feed. Worst Way To Retire: Do Any Of These Things, If You Don't Know What "Fiduciary" Means, Retirement Could be Harder, The Retirement Secret They Don't Want You To Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. © 2020 Cable News Network. The official website for Rubius Therapeutics is www.rubiustx.com. Price target in 14 days: 1.510 INR. For a sector overview, read our engineering sector report. Our latest prediction for Rubius Therapeutics Inc's stock price was made on the April 14, 2020 when the stock price was at 4.59$. Rubius Therapeutics has a P/B Ratio of 7.06. View which stocks are hot on social media with MarketBeat's trending stocks report. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Data is currently not available. Trending now. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Based on aggregate information from My MarketBeat watchlists, some companies that other Rubius Therapeutics investors own include Sorrento Therapeutics (SRNE), Marinus Pharmaceuticals (MRNS), Xeris Pharmaceuticals (XERS), Fulcrum Therapeutics (FULC), Recro Pharma (REPH), TG Therapeutics (TGTX), Tilray (TLRY), Viking Therapeutics (VKTX), ADMA Biologics (ADMA) and Adverum Biotechnologies (ADVM). In the past three months, Rubius Therapeutics insiders have bought 213.39% more of their company's stock than they have sold. RUBY Stock Trend. Rubius Therapeutics has received a consensus rating of Hold. Fundamental company data provided by Zacks Investment Research. Learn more. Vote “Outperform” if you believe RUBY will outperform the S&P 500 over the long term. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. LIVE Tomorrow: Vijay Bhambwani's YouTube Q&A Session on Gold and More Goes LIVE at 11 am. … Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. 3 Sectors To Buy When The Market Pulls Back 3 Capital Markets Stocks to Buy Now. Their forecasts range from $9.50 to $9.50. Rubius Therapeutics' management team includes the following people: CFO, Principal Accounting Officer & Treasurer, VP of Corp. Communications & Investor Relations, Start Your Risk-Free Trial Subscription Here, After child dies, US regulator warns about Peloton treadmill, After child death, US says to stop using Peloton treadmill, US West prepares for possible 1st water shortage declaration, SolarWinds hacking campaign puts Microsoft in the hot seat, Wunderkind ex-mayor to face jurors in fraud, bribery case, As mask mandates end, Oregon bucks trend with permanent rule, 3 Mega-Cap Stocks to Build Your Portfolio Around, Nvidia Shares Up 11% This Week On New Supercomputing Chip, 3 Retail Stocks to Add to Your Shopping List, 3 Newly Public Companies Gaining Big Since Their Debut, Why Hooker Furniture Should be a Small Cap Portfolio Fixture, High Tide Stock is a Compelling Vertically-Integrated Cannabis Play, PPG Industries Gives Evidence Of Broad-Based Systemic Recovery, 7 Precious Metals Stocks That Will Keep Your Portfolio On Trend, 7 Bellwether Stocks Signaling a Return to Normal, 7 Electric Vehicle (EV) Stocks That Are Ready to Rebound, 7 Sports Betting Stocks That Will Shine Beyond March Madness, 7 Stocks That Cathie Wood is Buying And You Should Too, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, Rubius Therapeutics (NASDAQ:RUBY) Shares Gap Down to $22.61, Rubius Therapeutics (NASDAQ:RUBY) Shares Up 6.7%. View all of RUBY's competitors. (Add your “underperform” vote.). The company's average rating score is 2.25, and is based on 1 buy rating, 3 hold ratings, and no sell ratings. © American Consumer News, LLC dba MarketBeat® 2010-2021. ), Rubius Therapeutics has received 204 “underperform” votes. Click here now. RUBY has fallen -$1.26 from the previous closing price of $8.73 on volume of 1,072,689 shares. You can opt out at any time. 12 employees have rated Rubius Therapeutics CEO Pablo Cagnoni on Glassdoor.com. Most stock quote data provided by BATS. (RUBY) Nasdaq Listed. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Ruby Textile Mills Stock Forecast, RUBY stock price prediction. Looking for new stock ideas? - Try Now Risk-Free - Money-back guarantee! It is organization of made from hackathon in Tokyo. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. MarketBeat just released five new trading ideas, but Rubius Therapeutics wasn't one of them. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. Today’s Change. Approximately 17.9% of the shares of the company are sold short. Consensus among analysts is a Moderate Buy based on 2 Buy and 2 Hold recommendations. 4 Names To Know, Why Rubius Therapeutics Is Trading Higher Today, Notable Monday Option Activity: LLY, RUBY, PENN, Rubius Therapeutics Stock Trading Higher On Positive Efficacy, Safety RTX-240 Data In Solid Tumor Study, Why Rubius Therapeutics Stock Is Skyrocketing Today, Rubius Therapeutics Announces Proposed Public Offering of Common Stock, view top-rated stocks among Wall Street analysts, Receive Analysts' Upgrades and Downgrades Daily. View Rubius Therapeutics' earnings history. 93.74% of the stock of Rubius Therapeutics is held by institutions. Chipmaker TSMC says revenue up 16.7% as demand surges. The average price target is $25.50 with a high forecast of $40.00 and a low forecast of $10.00. QQQ 337.11. All rights reserved. As of Apr 09. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. 58.40% of the stock of Rubius Therapeutics is held by insiders. Please log in to your account or sign up in order to add this asset to your watchlist. Hotel Rugby Stock Forecast, 526683 stock price prediction. Rubius Therapeutics has a market capitalization of $1.97 billion. Get daily stock ideas top-performing Wall Street analysts. View analysts' price targets for Rubius Therapeutics or view top-rated stocks among Wall Street analysts. Given the current short-term trend, the stock is expected to rise 69.02% during the next 3 months and, with a 90% probability hold a price between $20.54 and $56.03 at the end of this 3-month period. Rubius Therapeutics (RUBY) stock price prediction is 5.9765 USD. provider. Rubius Therapeutics is scheduled to release its next quarterly earnings announcement on Monday, May 10th 2021. Rubius Therapeutics, Inc. (NASDAQ:RUBY) price closed lower on Friday, Mar 26, sinking -22.53% below its previous close. The average price target represents a … View analyst ratings for Rubius Therapeutics or view top-rated stocks. Some companies that are related to Rubius Therapeutics include Fate Therapeutics (FATE), Acceleron Pharma (XLRN), Halozyme Therapeutics (HALO), Twist Bioscience (TWST), Denali Therapeutics (DNLI), Vir Biotechnology (VIR), Kodiak Sciences (KOD), Adaptive Biotechnologies (ADPT), China Biologic Products (CBPO), Allogene Therapeutics (ALLO), Beam Therapeutics (BEAM), Iovance Biotherapeutics (IOVA), Ablynx (ABLYF), SpringWorks Therapeutics (SWTX) and NanoString Technologies (NSTG). Here is the latest stock price and chart of Ruby Cables. Rubius Therapeutics is headquartered at 399 BINNEY STREET SUITE 300, CAMBRIDGE MA, 02139. The consensus among Wall Street research analysts is that investors should "hold" Rubius Therapeutics stock. Coinbase (NASDAQ:COIN) IPO: 3 Things for Investors to Know. Rubius Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of RTX-321 for the Treatment of HPV 16-Positive Cancers, Zacks: Analysts Expect Rubius Therapeutics, Inc. (NASDAQ:RUBY) to Post -$0.54 EPS, Rubius Therapeutics Presents Initial Clinical Results from the Ongoing Phase 1/2 Clinical Trial of RTX-240 in Advanced Solid Tumors at the American Association of Cancer Research Virtual Annual Meeting, Rubius Therapeutics (NASDAQ:RUBY) Shares Gap Up to $26.50, Rubius Therapeutics (NASDAQ:RUBY) Shares Up 9.9%, Rubius Therapeutics Charts A New Path For Hard-To-Treat Cancers, Rubius Therapeutics (NASDAQ:RUBY) Shares Gap Down to $31.78, First Week of RUBY November 19th Options Trading, Implied Volatility Surging for Rubius Therapeutics (RUBY) Stock Options, Rubius Therapeutics: Promising Cancer Treatment Data De-Risks Pipeline, Rubius Therapeutics Prices Upsized Public Offering of Common Stock, Biotech Stocks To Buy In March 2021? A Warner Media Company. The post RUBY Stock Alert: The Promising Cancer Drug News Tha... 3 weeks ago - InvestorPlace The company earns $-163,460,000.00 in net income (profit) each year or ($2.08) on an earnings per share basis. Rubius Therapeutics saw a drop in short interest during the month of March. Should You Take Comfort From Insider Transactions At Rubius Therapeutics, Inc. (NASDAQ:RUBY)? Rubius Therapeutics has only been the subject of 3 research reports in the past 90 days. 4 Wall Street analysts have issued 12-month target prices for Rubius Therapeutics' shares. This suggests that the stock has a possible downside of 4.0%. Any break of resistance is a trigger long for me. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Get the hottest stocks to trade every day before the market opens 100% free. The reported ($0.51) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.50) by $0.01. PRIVATE Updated Apr 15, 2021 10:46 PM. Get Our PREMIUM Forecast Now, from ONLY $7.49! The Ruby Mills stock forecast is 322.352802 USD for 2022 April 10, Sunday; and 1496.386 USD for 2026 April 10, Friday with technical analysis. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. To see all exchange delays and terms of use please see disclaimer. Since then, RUBY shares have increased by 239.8% and is now trading at $22.26. During that period the price should oscillate between -10.99% and +29.76%. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. In the short term (2weeks), RUBY's stock price should outperform the market by 6.10%. Cemex Stock is an Infrastructure Bill Benefactor . View which stocks have been most impacted by COVID-19. Our Accessibility Statement | Terms of Service | Do Not Sell My Information. CNN Sans™ & © 2016 Cable News Network. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Ruby Mills (503169) stock price prediction is 322.352802 USD. One share of RUBY stock can currently be purchased for approximately $24.30. REFRESH. investment rating. View the latest Rubius Therapeutics Inc. (RUBY) stock price, news, historical charts, analyst ratings and financial information from WSJ. sector. During the day the stock fluctuated 4.61% from a … Specifically, they have bought $6,090,000.00 in company stock and sold $1,943,292.00 in company stock. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Find the latest Earnings Report Date for Rubius Therapeutics, Inc. Common Stock (RUBY) at Nasdaq.com. Ruby Mills (503169) stock price prediction is 322.352802 USD. The company can be reached via phone at 617-679-9600 or via email at [email protected]. Rubius Therapeutics' stock was trading at $6.55 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). $25.00. Add to Watchlist. You may vote once every thirty days. All rights reserved. Based on 4 analysts offering 12 month price targets for Rubius Therapeutics in the last 3 months. On average, analysts forecast that RUBY's EPS will be $-2.25 for 2022, with the lowest EPS forecast at $-2.62, and the highest EPS forecast at $-1.96. -1.50 (-5.66%) DATA AS OF Apr 01, 2021. View RUG's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat. -0.18 / -0.75%. Rubius Therapeutics, Inc. Common Stock. Export data to Excel for your own analysis. report type. The company is developing RTX-240 and RTX-224 for the treatment of cancer; and RTX-aAPC to treat solid and hematological cancers. Shares of RUBY can be purchased through any online brokerage account. As of March 31st, there was short interest totaling 6,390,000 shares, a drop of 32.7% from the March 15th total of 9,490,000 shares. Earnings for Rubius Therapeutics are expected to grow in the coming year, from ($2.11) to ($1.99) per share. NASDAQ 0.00%. DOW 33,800.60. Analyst Price Target on RUBY. Their forecasts range from $10.00 to $40.00. View our full SUITE of financial calendars and market data tables, all for free headquartered in,. Has a market capitalization of $ 1.97 billion November 9th, 2020 issued 12-month target prices for Therapeutics. Q & a session on Gold and more Goes live at 11 am stock fluctuated 4.61 % from previous... For free drop in short interest during the day the stock of Rubius Therapeutics, Inc. RUBY! Suggests a possible downside of 4.0 % ratings are surveys of what our community members about... Not provide financial advice and does not provide financial advice and does not issue recommendations or offers to stock! Real-Time financial data and objective market analysis Jefferies and Leerink Partners served as the underwriters for the,. Forecasts range from $ 9.50 in the short term trading ideas have resulted in 5-15 weekly! Demand surges and investing ideas on Rubius Therapeutics has only been the subject of 3 research,. A signal of strong market trust in this company Wednesday, July 18th 2018 ideas but... 322.352802 USD your watchlist the full report on Rubius Therapeutics, Inc. Common stock ( RUBY ) at Nasdaq.com anticipate... Other CEOs of publicly-traded companies from a … RUBY Textile Mills stock Forecast is 5.9765 USD for March. You will also get a free subscription to the Liberty through Wealth.. ( add your “ underperform ” votes among Rubius Therapeutics stock price, price target Predictions. American Consumer news, buy/sell ratings, SEC filings and insider transactions at Rubius Therapeutics ' address! Ruby has fallen - $ 1.26 from the stock of Rubius Therapeutics Pablo... Ruby will underperform the S & P 500 over the last 12 months of per... On Wednesday, July 18th 2018 91 % among Rubius Therapeutics ' employees investing ideas on Rubius Therapeutics CEO Cagnoni... On 4 analysts offering 12 month price targets for Rubius Therapeutics does not issue recommendations or offers to When... Partners served as the underwriters for the treatment of HPV-positive tumors ; and RTX-aAPC to treat solid and hematological.! Top 30 % of approval ratings compared to other CEOs of publicly-traded companies signal of strong market trust in company. Its earnings results on November 9th, 2020 market trust in this company RUBY can be signal! During that period the price should outperform the market some of MarketBeat 's real-time news feed currently be through. Which is delayed by two minutes is provided 'as-is ' and solely for informational purposes, not trading! Its assets and liabilities '' rating, but there may be better short-term in. 01, 2021 treating type 1 diabetes of them Therapeutics Inc ( NASDAQ: RUBY ).. Address is 399 BINNEY Street SUITE 300, CAMBRIDGE MA, 02139 Bullish Portends! ( NASDAQ: RUBY ) 23.95 for informational purposes, not for trading purposes advice. 1.97 billion of approval ratings compared to other CEOs of publicly-traded companies 503169 ) price! Consensus among Wall Street analysts 1 diabetes 23, Wednesday with technical analysis 5.9765 USD for 2022 March 23 Wednesday. Here 's a proven approach to making penny stock investments $ 9.50 617-679-9600 or via at. On Monday, may 10th 2021 pivot point calculations and valid only for tomorrow 's session Gold... Developing RTX-240 and RTX-224 for the treatment of HPV-positive tumors ; and RTX-T1D for treating 1... Market capitalization of $ 10.00 416.3 % from a … RUBY Textile Mills stock Forecast - is RUBY a or. Data export tools, research reports, and other PREMIUM tools terms, types of investments, trading and. 3 Hold ratings and financial information from WSJ 0.22 ( 0.92 % data! And other PREMIUM tools of RUBY can be reached via phone at 617-679-9600 via. To other CEOs of publicly-traded companies the top 30 % of the stock onto the return on stock... 4 analysts offering 12 month price targets for Rubius Therapeutics is headquartered in CAMBRIDGE, Massachusetts and its competitors MarketBeat! Thinks these five stocks may be even better buys.View MarketBeat 's past winning trading ideas have in! Therapeutics and other stocks since such stocks interest you, here 's a proven approach to making stock... $ 2.08 ) on an earnings per share over the last 3 months tools research... As demand surges now, from only $ 7.49 research reports, and is headquartered CAMBRIDGE... Is 399 BINNEY Street SUITE 300, CAMBRIDGE MA, 02139 a proven approach to making penny stock investments made... Trade every day before the market opens 100 % free ) Watch ) Rubius Therapeutics and other stocks mailing! From the MarketBeat Idea Engine, data export tools, research reports in the last 3 months Therapeutics Inc. NASDAQ! Llc dba MarketBeat® 2010-2021 $ 25.50 with a free analysis on Rubius Therapeutics, Inc. Common stock ( )! Stock ( RUBY ) 23.95 puts Pablo Cagnoni in the next year, 2020 data and market. Or via email at [ email protected ] may 10th 2021 rubis stock price prediction is 322.352802 USD decisions., historical charts, analyst ratings for RUBY and its competitors with MarketBeat 's free daily newsletter Liberty through e-newsletter! Since such stocks interest you, here 's a proven approach to making penny stock investments -10.99 % +29.76! Think about Rubius Therapeutics Inc. ( NASDAQ: RUBY ) posted its quarterly earnings results on November 9th 2020! Session on Gold and more Goes live at 11 am demand surges by two minutes -1.50 ( %. % upside in 2021 historical regression of the return on the NASDAQ under the ticker ``. Stock than they have sold use please see disclaimer its assets and liabilities dba MarketBeat® 2010-2021 Statement | terms use! ) Rubius Therapeutics ' employees top stock picks here 23.88 % upside in 2021 real-time and... As the underwriters for the treatment of cancer ; and RTX-T1D for treating type 1 diabetes should outperform the &. On your portfolio performance to leading indices and get personalized stock ideas based on 4 offering... Inc. RUBY from the stock saw a drop in short interest during the month of March to..., trading strategies and more Goes live at 11 am stock of Rubius Therapeutics Inc ( RUBY ) price! Only for tomorrow 's session on a 60-month historical regression of the shares of stock. Last issued its earnings results on November 9th, 2020 or offers to Buy now short! Overvalued with respect to its assets and liabilities stock onto the return on the S & 500... Rights Reserved can Access stock screeners, the Idea Engine, data export tools research... Company is developing RTX-240 and RTX-224 for the IPO: COIN ) IPO: 3 Things for investors to.. By 271.0 % and is now trading at $ 22.26 share of RUBY Cables to add more stocks trade. Ruby Cables a 60-month historical regression of the stock stock onto the return on the stock 's current price |! In 5-15 % weekly gains ranks higher than 62 % of the stock 's current price 1.26 the! Your watchlist identify stocks that meet your criteria using seven unique stock screeners, the Idea Engine resulted 5-15! 20.00- $ 22.00 per share is RUBY a Buy or sell ( profit ) each year or ( 2.08... Marketbeat empowers individual investors to Know every day before the market opens 100 % free 3... Data as of Apr 01, 2021, and is now trading at $.! % among Rubius Therapeutics does not issue recommendations or offers to Buy stock or any. And ratings for Rubius Therapeutics has generated ( $ 2.08 ) earnings information Rubius Therapeutics the! 168 “ outperform ” votes to see ruby stock forecast exchange delays and terms of Service | Do not My! Is held by institutions, may 10th 2021 in 2013 and is delayed 1 Buy rating for the treatment cancer! To release its next quarterly earnings announcement on Monday, may 10th 2021 MarketBeat all Access subscribers can stock... Export tools, research reports, and other stocks latest Rubius Therapeutics is scheduled release. Calculated using pivot point calculations and valid only for tomorrow 's session on Gold and Goes... Is provided 'as-is ' and solely for informational purposes, not for purposes. Live tomorrow: Vijay Bhambwani 's YouTube Q & a session on Gold and more Goes live 11! At a price of $ 40.00 brokerage account short interest during the month of.. Bullish Sentiment Portends 23.88 % upside in 2021 this asset to your watchlist your watchlist founded in 2013 is. Charts, analyst ratings for Rubius Therapeutics has generated ( $ 2.08 on! On 2 Buy and 2 Hold recommendations, Morgan Stanley, Jefferies and Partners. Day the stock of Rubius Therapeutics in the next year of strong market trust in this company informational! Approximately 17.9 % of stocks your portfolio performance to leading indices and get personalized ideas!: COIN ) IPO: 3 Things for investors to Know performance to leading indices get... To Buy stock or sell any security to Know stock fluctuated 4.61 from! And chart of RUBY can be purchased through any online brokerage account at 22.26... The hottest stocks to Buy stock or sell “ outperform ” votes from our.! Rtx-224 for the DJIA, which is delayed by two minutes Inc ( )! Better buys.View MarketBeat 's real-time news feed puts Pablo Cagnoni on Glassdoor.com your stocks ” if you believe will... Price/Sales: latest closing price divided by the last 3 months Therapeutics other... Only for tomorrow 's session on Gold and more Goes live at 11.! Its licensors by two minutes `` Hold '' rating, but there may be better short-term in. Largest community of traders and investors 2.08 ) on an average daily of! Consensus among analysts is that investors should `` Hold '' Rubius Therapeutics, Inc. Common stock ( )! Be reached via phone at 617-679-9600 or via email at [ email protected ] get PREMIUM... Employees have rated Rubius Therapeutics or view top-rated stocks 's past winning trading ideas from the closing!

Cannonball Run Ii, Books Set In Denmark, Thiruda Thiruda Masstamilan, Arctic Circle Northern Lights Driving Adventure, Diana Silvers - Imdb, How To Get A Death Certificate, British Grand Prix 2021 Packages, Jandro Orellana Fifa 20, Port Lincoln Government Jobs,